# VS Trust: overview
UVIX · CBOE · CIK 1793497 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31
Pages: [Overview](/companies/uvix.md) · [Financials](/companies/uvix/financials.md) · [Filings](/companies/uvix/filings.md) · [Insiders](/companies/uvix/insiders.md)
Revenue is not reported in this company’s XBRL financial statements.
## Last eight quarters
Not reported.
## Last five fiscal years
| Line item | Unit | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: |
| Revenue | $ | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported |
| Free cash flow | $ | not reported | not reported | not reported | not reported |
- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.
Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.
## Insider purchases and sales
The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/uvix/insiders.md)
None in coverage.
## Funds that report holding it
From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)
| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $26.5m | 1,115,800 | Put | Added +97,500 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $20.9m | 877,000 | Call | Added +33,600 |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $10.1m | 426,700 | Call | Added +172,800 |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $9.7m | 410,000 | | Added +350,000 |
| [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $5.2m | 218,400 | Call | Reduced −81,200 |
| [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $4.6m | 193,100 | Put | Reduced −138,400 |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $4.3m | 180,300 | Put | Reduced −23,700 |
| [NICOLET BANKSHARES INC](/funds/1174850.md) | 2026-06-30 | $2.9m | 120,972 | | Added +10,059 |
| [MILLENNIUM MANAGEMENT LLC](/funds/1273087.md) | 2026-06-30 | $2.9m | 120,000 | Put | New +120,000 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $2.4m | 100,100 | | Added +100 |
## Recent filings
[All 87 filings](/companies/uvix/filings.md)
| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-07 | 21:27 ET | [S-1/A](/filings/0001213900-26-107622.md) | Registration statement, amended | 0001213900-26-107622 |
| 2026-08-17 | 21:30 ET | [S-1](/filings/0001213900-26-090839.md) | Registration statement | 0001213900-26-090839 |
| 2026-08-14 | 17:09 ET | [10-Q](/filings/0001213900-26-089738.md) | Quarterly report, period 2026-06-30 | 0001213900-26-089738 |
| 2026-06-17 | 21:25 ET | [8-K](/filings/0001213900-26-069735.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-069735 |
| 2026-05-12 | 21:10 ET | [10-Q](/filings/0001213900-26-055187.md) | Quarterly report, period 2026-03-31 | 0001213900-26-055187 |
| 2026-03-31 | 20:33 ET | [10-K](/filings/0001213900-26-037527.md) | Annual report, period 2025-12-31 | 0001213900-26-037527 |
| 2025-11-13 | 19:31 ET | [10-Q](/filings/0001213900-25-109885.md) | Quarterly report, period 2025-09-30 | 0001213900-25-109885 |
| 2025-08-13 | 21:27 ET | [10-Q](/filings/0001213900-25-075845.md) | Quarterly report, period 2025-06-30 | 0001213900-25-075845 |
| 2025-05-15 | 21:12 ET | [10-Q](/filings/0001213900-25-044385.md) | Quarterly report, period 2025-03-31 | 0001213900-25-044385 |
| 2025-03-28 | 20:57 ET | [10-K](/filings/0001013762-25-004207.md) | Annual report, period 2024-12-31 | 0001013762-25-004207 |
## Latest annual report
[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001213900-26-037527.md), filed Mar 31, 2026.
## Forecast league
Not in this season’s league. [This season’s league](/leagues.md)
## About the filer
- CIK: 1793497
- Tickers: UVIX, SVIX
- Exchange: CBOE
- SIC code: 6221 Commodity Contracts Brokers & Dealers
- State of incorporation: DE
- Filer category: Non-accelerated filer
Smaller reporting company
Emerging growth company
Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.